# LGM Pharma Solutions, LLC – FDA Inspection, Mar 1, 2024

Source: https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1d4efc76-d6cb-4820-a2a8-d28f1e3bc96a
Source feed: FDA_Inspections

> FDA inspection 1230374 of LGM Pharma Solutions, LLC, March 01, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230374
- Company Name: LGM Pharma Solutions, LLC
- Inspection Date: 2024-03-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1317740 - 2026-05-18](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/862f3c9a-5369-473a-b4fe-259a971eb45c)
- FDA Inspection 1232056 - 2025-01-24
- FDA Inspection 1120565 - 2020-01-31
- [FDA Inspection 1062404 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/ca7148c1-4596-4434-a574-793ec136f744)
- [FDA Inspection 1029466 - 2017-10-20](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/bec6dcf5-e6db-4838-a7c9-aa6757434988)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [FDA Associated Person](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)

Company: https://www.keypedia.com/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
